Reed Kathrein

Henry Schein

CVET DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Covetrus (CVET) Investors of Today’s Deadline to Move for Lead Plaintiff | 11/29/2019

… prospects and performance of Covetrus, which was formed through a spin-off and merger of the Animal Health Business of Henry Schein with Vets First Choice (“VFC”). Specifically, Defendants repeatedly assured investors that the integration … of Henry Schein’s Animal Health Business,” said Hagens Berman partner Reed Kathrein. If you purchased shares of Covetrus and suffered significant losses, click here to discuss your legal rights with Hagens Berman . Whistleblowers: Persons with …

Follow Reed Kathrein:    

Biotech

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys, Firm Investigating Possible Securities Fraud | Benzinga | 11/14/2019

… kidney disease (“CKD”) patients. On Nov. 4, 2019, research firm Plainview LLC published a scathing report entitled “The Next Big Biotech Blow-Up,” alleging that “FibroGen has been mysteriously unforthcoming “ about the highly anticipated safety … misled investors about the safety its core drug candidate,” said Reed Kathrein, the Hagens Berman partner leading the investigation. If you purchased shares of FibroGen and suffered significant losses, click here to discuss your legal …

Qiagen

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Qiagen (QGEN) Investors with Significant Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud | Globe Newswire | 11/2/2019

… to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Hagens Berman reminds Qiagen N.V. ( NYSE: QGEN ) investors of the firm’s ongoing investigation of possible violations of federal … falsely portrayed demand for its products,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Qiagen should consider their options to help in the investigation or take advantage of the SEC …

BeiGene

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds BeiGene, Ltd. (BGNE) Investors of Ongoing Investigation of Possible Securities Fraud: Investors Who Suffered Losses Encouraged to Contact Firm | Globe Newswire | 10/30/2019

… if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 29, 2019 (GLOBE NEWSWIRE) – Hagens Berman reminds investors in BeiGene, Ltd. (NASDAQ: BGNE) of the firm’s investigation of possible violations of federal securities laws … propriety of the company’s financial reporting,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding BeiGene should consider their options to help in the investigation or take advantage of the SEC …

GeneSight

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS MYGN INVESTORS OF CLASS ACTION: Myriad Genetics (MYGN) Investors Who Suffered Significant Losses are Encouraged to Contact the Firm | Globe Newswire | 10/24/2019

510) 725-3000 MYGN Securities Class Action: According to the Complaint , Defendants misled investors about Myriad Genetics’ GeneSight®, a DNA genotyping test to aid psychotropic drug selection for depressed patients. The Complaint alleges Defendants repeatedly promoted … whether Myriad misrepresented GeneSight®’s benefits,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Myriad should consider their options to help in the investigation or take advantage of the SEC …

MacroGenics

MGNX INVESTOR REMINDER: Hagens Berman Reminds MacroGenics (MGNX) Investors of Securities Class Action, Encourages Investors Who Lost $50,000+ to Contact the Firm | Globe Newswire | 10/8/2019

Class-action law firm urges MGNX investors who have suffered significant losses (in excess of $50,000) to learn their shareholder rights October 07, 2019 20:09 ET Source: Hagens Berman Sobol Shapiro LLP SAN FRANCISCO, Oct. 07, Hagens Berman Sobol Shapiro LLP reminds MGNX investors of a securities fraud lawsuit filed against MacroGenics, Inc. (MGNX). CLASS PERIOD: Feb. 6, 2019 – June 3, 2019 LEAD PLAINTIFF DEADLINE: Nov. 12, 2019 Call : Reed …

Myriad Genetics

MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm | Globe Newswire | 10/8/2019

Call: Reed Kathrein, who is leading the firm’s investigation: (510) 725-3000 MYGN Securities Class Action: According to the Complaint , Defendants misled investors about Myriad Genetics’ GeneSight®, a DNA genotyping test to aid psychotropic drug selection for depressed patients. The Complaint alleges Defendants repeatedly promoted the GeneSight® product, while concealing that GeneSight® lacked evidence or information sufficient to support tests in its current form, including the validity of its purported benefits …

Omnicell

OMNICELL (OMCL) 1-DAY DEADLINE ALERT: Hagens Berman Reminds Omnicell (OMCL) Investors of September 16, 2019 Lead Plaintiff Deadline, Investors Who Lost $50,000+ May Contact the Firm | 9/15/2019

[email protected] . According to the Complaint , Defendants misled investors by concealing that Omnicell (1) engaged in improper revenue recognition, (2) experienced weaker demand for new product lines than it previously projected, (3) would be required to write off certain obsolete inventory, and (4) misclassified certain expenses as capitalized expenditures. “We’re focused on investors’ losses, whether Omnicell and senior management engaged in accounting misconduct,” said Hagens Berman partner Reed Kathrein. Whistleblowers …

Oasmia Pharmaceutical

OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline | Globe Newswire | 9/11/2019

… filed lawsuit September 10, 2019 20:08 ET Source: Hagens Berman Sobol Shapiro LLP SAN FRANCISCO, Hagens Berman reminds investors in Oasmia Pharmaceutical AB ( NASDAQ: OASM ) of the September 27, 2019 lead plaintiff deadline in a … investors about improper related-party transactions,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Oasmia should consider their options to help in the investigation or take advantage of the SEC …

Evolent Health

EVH LITIGATION DEADLINE REMINDER: Hagens Berman Reminds Evolent Health (EVH) Investors of October 7, 2019 Lead Plaintiff Deadline; Investors Who Lost $100,000+ May Contact the Firm | Globe Newswire | 9/4/2019

… Reed Kathrein. Whistleblowers: Persons with non-public information regarding Evolent Health should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected] . About Hagens Berman Hagens Berman …

Ra Medical Systems

4-DAY RMED INVESTOR DEADLINE: Hagens Berman Reminds Ra Medical (RMED) Investors of August 9, 2019 Lead Plaintiff Deadline | Globe Newswire | 8/6/2019

[email protected] . According to the complaint , Ra Medical’s Initial Public Offering (“IPO”) materials misrepresented and concealed sales personnel issues and problems in the Company’s manufacturing process for catheters. “We’re focused on investors’ losses and whether Defendants misled investors about production and sales-execution issues,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Ra Medical Systems should consider their options to help in the investigation or …

MiMedx

INS CLASS ACTION ALERT: Hagens Berman Alerts Intelligent Systems (INS) Investors to Lead Plaintiff Deadline, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm | Globe Newswire | 7/16/2019

… misled investors by concealing (1) Intelligent Systems’ Audit Committee’s financial expert previously engaged in accounting fraud as the CEO of MiMedx Group, (2) the Company’s CEO engaged in undisclosed related-party transactions and had an … the economic substance of certain transactions,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Intelligent Systems should consider their options to help in the investigation or take advantage of the …

MiMedx Group

INS CLASS ACTION ALERT: Hagens Berman Alerts Intelligent Systems (INS) Investors to Lead Plaintiff Deadline, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm | Globe Newswire | 7/16/2019

… misled investors by concealing (1) Intelligent Systems’ Audit Committee’s financial expert previously engaged in accounting fraud as the CEO of MiMedx Group, (2) the Company’s CEO engaged in undisclosed related-party transactions and had an … the economic substance of certain transactions,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding Intelligent Systems should consider their options to help in the investigation or take advantage of the …

Zogenix

ZGNX and APYX DEADLINE ALERT: Hagens Berman Reminds APYX and ZGNX Investors of Lead Plaintiff Deadlines | Globe Newswire | 6/7/2019

… Sobol Shapiro LLP reminds investors in ZGNX and APYX of immediately approaching lead plaintiff deadlines in pending securities class actions. Zogenix, Inc. (NASDAQ: ZGNX) CLASS PERIOD: Feb. 6, 2019 - April 8, 2019 LEAD PLAINTIFF DEADLINE … move the Court no later than June 11, 2019. Contact Reed Kathrein, who is leading the firm’s investigation of this case, by calling 510-725-3000 or emailing [email protected] . Apyx Medical Corporation (NASDAQ: APYX) CLASS PERIOD …

iRhythm

IRTC INVESTIGATION REMINDER: Hagens Berman Reminds iRhythm Technologies (IRTC) Investors of the Firm’s Ongoing Investigation, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm | Benzinga | 5/2/2019

iRhythm Technologies, Inc. (NASDAQ: IRTC ) of the firm’s ongoing investigation of possible securities law violations. If you purchased or otherwise acquired IRhythm Technologies securities before March 27, 2019, suffered significant losses, and wish to learn more about the investigation contact Hagens Berman: https://www.hbsslaw.com/cases/IRTC or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected] . Between March 13, 2019 and March 27 …